RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Novartis AG

A collection of news and information related to Novartis AG published by this site and its partners.

Top Novartis AG Articles see all

Displaying items 1-5
  • New Novartis heart failure drug cuts risk by a fifth

    BARCELONA (Reuters) - A new heart failure drug from Novartis cut the risk of both cardiovascular death and hospitalization by a fifth in a keenly awaited study, boosting hopes for a product that is seen as a multibillion-dollar seller.
  • Exclusive: U.S. approval of Merck cancer immunotherapy expected soon

    Exclusive: U.S. approval of Merck cancer immunotherapy expected soon
    U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...

    No biotech copycat drug lift off before 2017: Novartis CEO

    BASEL Switzerland (Reuters) - Swiss drugmaker Novartis AG does not expect copycat versions of biotech drugs to play an important role in the healthcare system for another three to five years, its chief executive said on Monday. Novartis' generics unit...

    Lilly psoriasis drug impresses; battle nears with Amgen, Novartis

    (Reuters) - An experimental new psoriasis treatment from Eli Lilly and Co proved superior to Amgen Inc's blockbuster Enbrel, drawing it closer to a potential marketing battle with new products being developed by Amgen and Novartis AG. Based on...

    EU regulator warns on possible MS drugs side effects

    FRANKFURT (Reuters) - Europe's drug safety regulator said multiple sclerosis treatments known as interferon beta need stronger label warnings because some patients treated with the drugs have suffered side effects affecting the kidney and other organs. A...